2012 annual financial data
PTC Therapeutics 2012 Operating margin
Direct answer
Operating margin was -93.15%.
Operating income was -26,808,181 USD and net income was -26,235,102 USD.
Operating cash flow was -47,927,791 USD.
Get free PTC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 28,779,078 USD
- Operating income
- -26,808,181 USD
- Net income
- -26,235,102 USD
- Operating cash flow
- -47,927,791 USD